Patent Exhaustion/First Sale/Misuse as Affirmative Claims

New Jersey Law Journal, Vol. 201, No. 13, pp. 1003-1004, September 27, 2010

2 Pages Posted: 27 Sep 2010

See all articles by Yee Wah Chin

Yee Wah Chin

Ingram Yuzek Gainen Carroll & Bertolotti, LLP

Date Written: August 30, 2010

Abstract

The doctrines of patent exhaustion, or first sale, and patent misuse are generally only considered affirmative defenses to patent infringement claims. However, under MedImmune, where patent misuse caused or threatened injury to an entity, that entity may assert misuse as an independent claim. Moreover, several recent precedents indicate that patent exhaustion or misuse may also be affirmative claims. This paper discusses these developments.

Keywords: patent exhaustion, first sale, patent misuse, patent affirmative defenses, patent affirmative claims, MedImmune, ExcelStor, B. Braun Medical

JEL Classification: K39, K49, O34

Suggested Citation

Chin, Yee Wah, Patent Exhaustion/First Sale/Misuse as Affirmative Claims (August 30, 2010). New Jersey Law Journal, Vol. 201, No. 13, pp. 1003-1004, September 27, 2010, Available at SSRN: https://ssrn.com/abstract=1683664

Yee Wah Chin (Contact Author)

Ingram Yuzek Gainen Carroll & Bertolotti, LLP ( email )

250 Park Avenue
New York, NY 10177
United States

HOME PAGE: http://www.ywc-antitrust.com

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
111
Abstract Views
661
rank
272,342
PlumX Metrics